Synthesis and Biological Characterisation of Novel N-Alkyl-Deoxynojirimycin a-Glucosidase Inhibitors

Illuminating glucosidases: The shown photoaffinity probe for endoplasmic reticulum (ER) -glucosidases was found to be a highly potent inhibitor of -glucosidase I in vitro and equally effective at inhibiting cellular ER glucosidases, as determined by a free oligosaccharide (FOS) analysis. The N-alkyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chembiochem : a European journal of chemical biology 2009-04, Vol.10 (6), p.1101-1105
Hauptverfasser: Rawlings, Amy J, Lomas, Hannah, Pilling, Adam W, Lee, Marvin J-R, Alonzi, Dominic S, Rountree, J S Shane, Jenkinson, Sarah F, Fleet, George W J, Dwek, Raymond A, Jones, John H, Butters, Terry D
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Illuminating glucosidases: The shown photoaffinity probe for endoplasmic reticulum (ER) -glucosidases was found to be a highly potent inhibitor of -glucosidase I in vitro and equally effective at inhibiting cellular ER glucosidases, as determined by a free oligosaccharide (FOS) analysis. The N-alkylated deoxynojirimycin compound, N-(6-(4-azido-2-nitrophenylamino)hexyl)-1-deoxynojirimycin (6) was synthesised as a potential photoaffinity probe for endoplasmic reticulum (ER) -glucosidases I and II. Surprisingly this compound was a highly potent inhibitor of -glucosidase I (IC50, 17 nM) in an in vitro assay and proved equally effective at inhibiting cellular ER glucosidases, as determined by a free oligosaccharide (FOS) analysis. A modest library of compounds was synthesised to obtain structure-activity information by variation of the N-alkyl chain length and modifications to the azido-nitrophenyl group. All of these compounds failed to improve on the efficacy of compound 6, but most showed greater enzyme inhibitory potency than N-butyl-deoxynojirimycin (NB-DNJ), a pharmacological agent that has been evaluated for the treatment of several viruses for which infectivity is dependent on host cell glycosylation.
ISSN:1439-4227
1439-7633
DOI:10.1002/cbic.200900025